MAYBAKER - May & Baker Nigeria
Manufacturing and Distribution of Pharmaceutical and Consumer goods
|Live Trading Feed||Growth & Valuation|
|Opening Price:||3.65||Earnings Per Share:||--|
|Day's Low Price:||--||Price/Earning Ratio:||--|
|Day's High Price:||--||Dividend Per Share:||--|
|Traded Volume:||35,979||Dividend Yield:||--|
|Number of Deals:||10||Shares Outstanding:||1.73b|
MAYBAKER Stock Market Performance
The current share price of May & Baker Nigeria (MAYBAKER) is NGN 3.65. The MAYBAKER stock closed its last trading day (Thursday, January 21, 2021) at 3.65 NGN per share on the Nigerian Stock Exchange, recording a 3.44% drop from its previous closing price of 3.78 NGN. MAYBAKER began the year with a share price of 3.51 NGN and has since gained 3.99% on that price valuation, ranking it 61st on the NSE in terms of year-to-date performance. Investors should, however, take caution of MAYBAKER's recent poor performance, having lost 5.19% of its value in the past four weeks. The table below details the last 10 trading days of activity of May & Baker Nigeria on the Nigerian Stock Exchange.
Profile of May & Baker Nigeria
May & Baker Nigeria operates in the Health Care sector. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.
|Factsheet of May & Baker Nigeria|
3/5 Sapara Street, Industrial Estate, Ikeja, Lagos
MAYBAKER Industrial Market Competitors
May & Baker Nigeria, issuers of the MAYBAKER stock on the Nigerian Stock Exchange, have a number of market competitors who are also engaged in the Health Care sector. The table below gives you an overview of the market standing of the top nine by year-to-date performance.
|Code||Name||Mkt. Cap.||L. Price||YearTD|
|GLAXOSMITH||Glaxo Smithkline Consumer||8.37b||7.00||+1.45%|
|EVANSMED||Evans Medical Plc||366.17m||0.50||+0.00%|
|NEIMETH||Neimeth International Pharma||3.80b||2.00||-10.3%|